Home > Animal Health & Nutrition > Veterinary Medical Devices > Companion Diagnostics Market
Companion Diagnostics Market Share
- Report ID: GMI3972
- Published Date: Jul 2019
- Report Format: PDF
Companion Diagnostics Market Share
Some of the notable players operating in the companion diagnostics market are :
- Roche
- Pfizer
- Merck
- Astra Zeneca
- Bristol Myers Squibb
- Amgen
- Biogen
- Eli Lilly
- Myriad Genetics
- Johnson & Johnson
- Becton
- Dickinson and Company
- Abbott
Industry players are adopting strategies such as new product launches, collaborations and mergers and acquisitions to grab high revenue share.
Frequently Asked Questions (FAQ) :
The market size of companion diagnostics exceeded USD 2 billion in 2018 and is poised to grow at over 19% CAGR between 2019 and 2025.
North America market size is estimated to expand at more than 18% CAGR during the forecast timeline impelled by increasing prevalence of chronic diseases and growing geriatric population susceptible to these diseases.
Asia Pacific market revenue is anticipated to witness around 20.5% growth through 2025. Government initiatives for providing effective treatment to cancer patients will propel the regional market expansion.
Some of the notable players operating in the market are Roche, Pfizer, Merck, Astra Zeneca, Bristol Myers Squibb, Amgen, Biogen, Eli Lilly, Myriad Genetics, Johnson & Johnson, Becton, Dickinson and Company, and Abbott.
Hospital end-use segment dominated around 40% market share in 2018 owing to increasing patient pool due to high prevalence of chronic disorders.
Companion Diagnostics Market Scope
×
Get a free sample of
Companion Diagnostics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below